Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

New Sheba Study Indicates COVID-19 Infection Can Lower Embryo Quality

COVID-19 Infection Can Lower Embryo Quality
The study marks the first attempt to examine the impact of COVID-19 infection on IVF

22 couples participated in a first-of-its-kind study on the impact of a recent COVID-19 infection in one of the two partners in relation to the quality of embryos during an in-vitro fertilization process.

Out of the 22 couples that participated in the study, 9 required a second IVF attempt 8 to 92 days after receiving a negative COVID-19 test. The study results indicated that exposure to COVID-19 did not affect the ovarian reserve among female participants, and although the sperm quality of male participants was somewhat lower, it was not clinically significant. However, the study did indicate that the quality of the embryos produced during the IVF procedure of the aforementioned 9 couples was lower.

COVID-19 Infection Can Lower Embryo Quality

According to Prof. Raoul Orvieto, Director of the Fertility and IVF Unit: “The production of eggs and sperm lasts for around three months and can be hampered by inflammatory responses, like the ones that occur as a result of a viral infection, which is the case with COVID-19.” Prof. Orvieto added: “Our study indicated that the quality of embryos producers during an IVF procedure for a couple in which one of the partners had previously contracted COVID-19 was significantly lower, and lead to a lower chance of successful implantation.”

Concluding the study, Prof. Orvieto remarked that based on its results, couples should wait for at least three months after one of the partners has been infected with COVID-19 before starting IVF treatments. This step is meant to ensure that the eggs and sperm used during the procedure were not harmed as a result of the inflammatory response created by the virus.

Breakthrough Research
News Jun 05.
Breakthrough Research Provides Pancreatic Cancer Patients with New Hope
Pancreatic cancer is a significant cause of cancer-related death, standing at fourth place globally. It is also the twelfth most common cancer type worldwide, with…
Read More
Sheba Study in collaboration with other medical institutions found an effective way of treatment, a type of cure for hemophilia.
News Jun 05.
Groundbreaking Sheba Study Indicates: New Gene Therapy Offers Rapid Cure for Hemophilia 
Hemophilia is a bleeding disorder that stems from a genetic mutation or alteration in the genes that encode clotting factor proteins, which are necessary for…
Read More
Sheba and Mayo Clinic merge Data-Sharing Network
News May 18.
Sheba and Mayo Clinic Partner to Transform Patient Care Through an Innovative Data-Sharing Network
Sheba Medical Center has joined the Mayo Clinic Platform Connect, a global data-sharing network that aims to revolutionize healthcare. The groundbreaking platform provides a safe,…
Read More